Details for New Drug Application (NDA): 062849
✉ Email this page to a colleague
NDA 062849 describes BACITRACIN ZINC-POLYMYXIN B SULFATE, which is a drug marketed by Naska and is included in one NDA. Additional details are available on the BACITRACIN ZINC-POLYMYXIN B SULFATE profile page.
The generic ingredient in BACITRACIN ZINC-POLYMYXIN B SULFATE is bacitracin zinc; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the bacitracin zinc; polymyxin b sulfate profile page.
The generic ingredient in BACITRACIN ZINC-POLYMYXIN B SULFATE is bacitracin zinc; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the bacitracin zinc; polymyxin b sulfate profile page.
Summary for 062849
| Tradename: | BACITRACIN ZINC-POLYMYXIN B SULFATE |
| Applicant: | Naska |
| Ingredient: | bacitracin zinc; polymyxin b sulfate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;TOPICAL | Strength | 500 UNITS/GM;10,000 UNITS/GM | ||||
| Approval Date: | Nov 13, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
